• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

Pyrazolo[1,5-a]pyridine-6-methanol (CAS No. 362661-88-9): A Key Intermediate in Modern Pharmaceutical Research

The compound Pyrazolo[1,5-a]pyridine-6-methanol, identified by its unique Chemical Abstracts Service (CAS) number CAS No. 362661-88-9, represents a significant intermediate in the realm of pharmaceutical chemistry. This heterocyclic compound, featuring a fused pyrazole and pyridine core, has garnered considerable attention due to its versatile structural framework and potential applications in drug discovery and development.

Pyrazolo[1,5-a]pyridine derivatives are known for their broad spectrum of biological activities, making them valuable scaffolds for designing novel therapeutic agents. The methanol substituent at the 6-position of the pyrazolo[1,5-a]pyridine ring enhances the compound's reactivity and functionalization potential, allowing for further chemical modifications that can tailor its pharmacological properties.

In recent years, significant advancements have been made in leveraging this compound for the development of innovative drugs. Researchers have explored its utility in creating molecules with antimicrobial, anti-inflammatory, and anticancer properties. The structural flexibility of Pyrazolo[1,5-a]pyridine-6-methanol enables the synthesis of derivatives that can interact with various biological targets, thereby opening new avenues for therapeutic intervention.

One of the most compelling aspects of Pyrazolo[1,5-a]pyridine-6-methanol is its role in the synthesis of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is often associated with various diseases, including cancer. By designing analogs of this compound that can selectively inhibit specific kinases, scientists aim to develop more effective and targeted therapies.

Recent studies have highlighted the potential of Pyrazolo[1,5-a]pyridine-6-methanol in developing treatments for neurological disorders. The compound's ability to cross the blood-brain barrier and interact with central nervous system receptors makes it an attractive candidate for drugs targeting conditions such as Alzheimer's disease and Parkinson's disease. Researchers are currently investigating its effects on neurotransmitter systems and its potential to modulate neuronal activity.

The methanol moiety in Pyrazolo[1,5-a]pyridine-6-methanol also plays a crucial role in its solubility and bioavailability. This feature is particularly important for pharmaceutical applications, as it ensures that the compound can be effectively delivered to target tissues in the body. Additionally, the methanol group provides a site for further functionalization, allowing chemists to modify the compound's properties to optimize its pharmacokinetic profile.

In conclusion, Pyrazolo[1,5-a]pyridine-6-methanol (CAS No. 362661-88-9) is a multifaceted compound with significant potential in pharmaceutical research. Its unique structural features and biological activities make it a valuable tool for developing novel therapeutic agents across various disease areas. As research continues to uncover new applications for this compound, it is likely to remain a cornerstone of drug discovery efforts in the coming years.

• 16205-46-2(Pyrazolo[1,5-a]pyridine-3-carboxylic acid)
• 474432-57-0({pyrazolo[1,5-a]pyridin-5-yl}methanol)
• 118054-97-0(3-(ethoxymethyl)-Pyrazolo[1,5-a]pyridine)
• 117782-76-0({pyrazolo[1,5-a]pyridin-3-yl}methanol)
• 127717-26-4(4-methyl-Pyrazolo[1,5-a]pyridine-3-methanol)
• 139452-20-3(6-Methylpyrazolo1,5-apyridine)
• 55899-41-7(Pyrazolo[1,5-a]pyridine-4-carboxylic acid)
• 139452-21-4(6-methylpyrazolo[1,5-a]pyridine-3-carboxylic acid)
• 40053-04-1(3-methyl-Pyrazolo[1,5-a]pyridine)
• 888735-61-3(6-(Hydroxymethyl)pyrazolo[1,5-a]pyridine-3-carboxylic acid)